← Learn

Rapamycin

also Rapamune, Sirolimus

Immune-suppressing drug, also called sirolimus

Sirolimus, also known as rapamycin and sold under the brand name Rapamune among others, is a macrolide compound that is used to coat coronary stents, prevent organ transplant rejection, treat a rare lung disease called lymphangioleiomyomatosis, and treat perivascular epithelioid cell tumour (PEComa). It has immunosuppressant functions in humans and is especially useful in preventing the rejection of kidney transplants. It is a mammalian target of rapamycin (mTOR) kinase inhibitor that reduces the sensitivity of T cells and B cells to interleukin-2 (IL-2), inhibiting their activity.

Information, not medical advice. Talk to a licensed doctor or pharmacist before starting or changing a treatment.

Research 10

  1. Promotion of Hair Regrowth by Transdermal Dissolvable Microneedles Loaded with Rapamycin and Epigallocatechin Gallate NanoparticlesPharmaceutics · 2022 · 26 citations
  2. Toxic Side Effects of Targeted Therapies and Immunotherapies Affecting the Skin, Oral Mucosa, Hair, and NailsAmerican Journal of Clinical Dermatology · 2018 · 365 citations
  3. Enhancing hair regrowth using rapamycin-primed mesenchymal stem cell-derived exosomesTheranostics · 2025 · 10 citations
  4. Cutaneous Side Effects of Sports SupplementsIndian Dermatology Online Journal · 2024
  5. Mammalian target of rapamycin complex 1 (m TORC 1) may modulate the timing of anagen entry in mouse hair folliclesExperimental Dermatology · 2012 · 31 citations
  6. Alopecia in patients treated with molecularly targeted anticancer therapiesAnnals of Oncology · 2015 · 65 citations
  7. Molecular pathways involved in hair follicle tumor formation: all about mammalian target of rapamycin?Experimental Dermatology · 2009 · 19 citations
  8. Clinical Application of Development of Nonantibiotic Macrolides That Correct Inflammation-Driven Immune Dysfunction in Inflammatory Skin DiseasesMediators of Inflammation · 2012 · 28 citations
  9. Effects of immunosuppressive peptidyl-prolyl cis-trans isomerase (PPIase) inhibitors, cyclosporin A, FK506, ascomycin and rapamycin, on hair growth initiation in mouse: immunosuppression is not required for new hair growthJournal of Dermatological Science · 1995 · 20 citations
  10. Differential expression of phospho‐S6 in hair follicle tumors: Evidence of mammalian target of rapamycin pathway activationJournal of Cutaneous Pathology · 2019 · 7 citations
All on OpenAlex →

Posts 2

  1. Does anyone have experience with Retrograde alopecia? Can’t seem to find any info on it.Reddit · 26 Dec 2025
  2. Posted this recently, but no reply, I wonder if people don’t like bad news?Reddit · 30 Jul 2024
View more on Reddit →